Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS58433B2 - Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou - Google Patents
[go: Go Back, main page]

JPS58433B2 - Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou - Google Patents

Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou

Info

Publication number
JPS58433B2
JPS58433B2 JP225675A JP225675A JPS58433B2 JP S58433 B2 JPS58433 B2 JP S58433B2 JP 225675 A JP225675 A JP 225675A JP 225675 A JP225675 A JP 225675A JP S58433 B2 JPS58433 B2 JP S58433B2
Authority
JP
Japan
Prior art keywords
pyrido
diazepine
tetrahydro
melting point
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP225675A
Other languages
Japanese (ja)
Other versions
JPS5180889A (en
Inventor
井出博之
山崎舜造
石倉雄二
中川晃
八谷照美
平野宗彦
野田寛治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP225675A priority Critical patent/JPS58433B2/en
Publication of JPS5180889A publication Critical patent/JPS5180889A/en
Publication of JPS58433B2 publication Critical patent/JPS58433B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

【発明の詳細な説明】 本発明は一般式(I) (式中、R1はフェニル基、ハロゲン原子、トリフルオ
ロメチル基が置換したフェニル基を、R2は水素原子、
低級アルキル基、又はハロゲン原子、低級シクロアルキ
ル基が置換した低級アルキル基を意味する)で表わされ
る新規なピリド−1,4−ジアゼピンジオン誘導体の製
造法に関するものである。
Detailed Description of the Invention The present invention is based on the general formula (I) (wherein R1 is a phenyl group, a halogen atom, or a phenyl group substituted with a trifluoromethyl group, R2 is a hydrogen atom,
The present invention relates to a method for producing a novel pyrido-1,4-diazepinedione derivative represented by a lower alkyl group, or a lower alkyl group substituted with a halogen atom or a lower cycloalkyl group.

更にくわしくは一般式(n) (式中、R及びRは前記と同じ意味を有する)で表わさ
れる化合物を酸化して前記一般式(I)で表わされる化
合物を製造する方法に関するものである。
More specifically, it relates to a method for producing a compound represented by the general formula (I) by oxidizing a compound represented by the general formula (n) (wherein R and R have the same meanings as above).

前記一般式(I)及び(1)におけるR1及びR2に就
いて更に詳細に説明すると、R1はフェニル基又は塩素
、臭素、弗素、沃素等のハロゲン原子、トリフルオロメ
チル基を仕置の位置に1〜2個置換したフエニル基を、
Rの低級アルキル基はメチル、エチル、プロピル、イソ
プロピル等の低級アルキル基を、置換した低級アルキル
基は塩素、臭素、弗素等のハロゲン原子又はシクロピル
、シクロブチル等の低級シクロアルキル基で置換された
低級アルキル基を表わす。
To explain R1 and R2 in the general formulas (I) and (1) in more detail, R1 is a phenyl group, a halogen atom such as chlorine, bromine, fluorine, or iodine, or a trifluoromethyl group at the position of 1. ~2 substituted phenyl groups,
The lower alkyl group of R is a lower alkyl group such as methyl, ethyl, propyl, or isopropyl, and the substituted lower alkyl group is a lower alkyl group substituted with a halogen atom such as chlorine, bromine, or fluorine, or a lower cycloalkyl group such as cyclopyl or cyclobutyl. Represents an alkyl group.

本発明の出発原料である一般式(n)で表わされる化合
物は2−アニリノ−3−アミノメチルピリジン誘導体に
モノハロゲン酢酸の反応性誘導体を反応させることによ
って収量よく得ることが出来る。
The compound represented by the general formula (n), which is the starting material of the present invention, can be obtained in good yield by reacting a 2-anilino-3-aminomethylpyridine derivative with a reactive derivative of monohalogenacetic acid.

本発明を反応式で示すと次の通りである。The reaction formula of the present invention is as follows.

本発明を実施するには前記の方法で得られた一般式(I
f)の化合物に酸化剤を作用させることによって行なわ
れる。
In carrying out the present invention, the general formula (I
This is carried out by reacting the compound f) with an oxidizing agent.

使用する酸化剤としては、過マンガン酸カリウム、二酸
化マンガン、三酸化クロム、重クロム酸カリウム、重ク
ロム酸ナトリウム、フェリシアン化ナトリウム、二酸化
セレン、過酸化水素、四酢酸鉛又は酢酸第二水銀等が挙
げられる。
Oxidizing agents used include potassium permanganate, manganese dioxide, chromium trioxide, potassium dichromate, sodium dichromate, sodium ferricyanide, selenium dioxide, hydrogen peroxide, lead tetraacetate, or mercuric acetate. can be mentioned.

さらに使用する溶媒は水、アセトン、テトラヒドロフラ
ン、ジオキサン、ピリジン、氷酢酸、硫酸、硝酸等の不
活性溶媒中から適宜選択される。
Further, the solvent used is appropriately selected from inert solvents such as water, acetone, tetrahydrofuran, dioxane, pyridine, glacial acetic acid, sulfuric acid, and nitric acid.

反応は室温又は加熱することによって行なわれ加熱する
と反応時間は短縮される。
The reaction is carried out at room temperature or by heating; heating shortens the reaction time.

本発明の方法によって得られた化合物は文献未載の新規
化合物であり、抗炎症作用及び中枢神経抑制作用、例え
ば鎮痛作用、筋弛緩作用、抗痙彎作用及び催眠作用等を
有し医薬品として産業上有用な化合物である。
The compound obtained by the method of the present invention is a new compound that has not been described in any literature, and has anti-inflammatory and central nervous system depressing effects, such as analgesic, muscle relaxant, anti-spasmodic and hypnotic effects, and is industrially available as a pharmaceutical. It is a very useful compound.

更に本発明はこの様にして得られた化合物を通常の薬学
上許容される技術によって、塩酸、臭化水素酸、硫酸、
リン酸、酢酸、クエン酸、フマール酸、マレイン酸等の
無機酸塩及び有機酸塩に導くことも包含している。
Furthermore, the present invention uses the compound thus obtained by adding hydrochloric acid, hydrobromic acid, sulfuric acid,
It also includes the production of inorganic and organic acid salts such as phosphoric acid, acetic acid, citric acid, fumaric acid, and maleic acid.

以下に実施例を示し本発明を更に具体的に説明する。EXAMPLES The present invention will be explained in more detail with reference to Examples below.

実施例 1 1 (m −トリフルオロメチルフェニル)−4−エ
チル−1,3,4,5−テトラヒドロ−3−オキソ−2
H−ピリド〔2,3−e〕〔1,4〕ジアゼピン1.0
gを酢酸12m1に溶解後、Na2Cr207 ・2H
700,89gを加え70℃で2時間撹拌した。
Example 1 1 (m-trifluoromethylphenyl)-4-ethyl-1,3,4,5-tetrahydro-3-oxo-2
H-pyrido[2,3-e][1,4]diazepine 1.0
After dissolving g in 12 ml of acetic acid, Na2Cr207 ・2H
700.89g was added and stirred at 70°C for 2 hours.

反応終了後減圧下に溶媒を留去し残渣に氷水を加え粗結
晶を得た。
After the reaction was completed, the solvent was distilled off under reduced pressure, and ice water was added to the residue to obtain crude crystals.

これをエーテルと石油エーテルの混合溶媒より再結晶し
て、無色針状晶の1−(m−トリフルオロメチルフェニ
ル)−4−エチル−1,3,4,5−テトラヒドロ−3
,5−ジオキソ−2H−ピリド(2,3−e〕〔1,4
〕ジアゼピン730mgを得た。
This was recrystallized from a mixed solvent of ether and petroleum ether to form colorless needle-like crystals of 1-(m-trifluoromethylphenyl)-4-ethyl-1,3,4,5-tetrahydro-3.
,5-dioxo-2H-pyrido(2,3-e)[1,4
] 730 mg of diazepine was obtained.

この物質の融点及び元素分析値は次の通りであつた。The melting point and elemental analysis values of this substance were as follows.

融 点 190〜191°C 元素分析値 C1□H14F3N30□ 理論値C:58.45 H:4.OI N:12.03
実測値C二58.39 H:3.98 N:12.12
実施例 2 l−(0−フルオロフェニル) −4−(2,2,2−
トリフルオロエチル) −1,3,4,5−テトラヒド
ロ−3−オキソ−2H−ピリド(2,3−e)(L4)
ジアゼピン3.4gを氷酢酸20m7に溶解後、無水ク
ロム酸3gを加え油浴上で2時間還流した。
Melting point 190-191°C Elemental analysis value C1□H14F3N30□ Theoretical value C: 58.45 H: 4. OI N:12.03
Actual value C2 58.39 H: 3.98 N: 12.12
Example 2 l-(0-fluorophenyl)-4-(2,2,2-
trifluoroethyl) -1,3,4,5-tetrahydro-3-oxo-2H-pyrido(2,3-e) (L4)
After dissolving 3.4 g of diazepine in 20 m7 of glacial acetic acid, 3 g of chromic anhydride was added and the mixture was refluxed on an oil bath for 2 hours.

反応後、減圧下溶媒を留去し残渣に氷水を加え粗結晶を
得た。
After the reaction, the solvent was distilled off under reduced pressure, and ice water was added to the residue to obtain crude crystals.

このものをアセトン−石油エーテルの混合溶媒で再結晶
して、無色針状晶の1−(0−フルオロフェニル)−4
−(2,2,2−トリフルオロチル)−1,3,4,5
−テトラヒドロ−3,5−ジオキソ−2H−ピリド〔2
,3−e)(1,4)ジアゼピン1.8gを得た。
This product was recrystallized from a mixed solvent of acetone and petroleum ether to form colorless needle-shaped crystals of 1-(0-fluorophenyl)-4.
-(2,2,2-trifluorotyl)-1,3,4,5
-tetrahydro-3,5-dioxo-2H-pyrido [2
, 3-e) 1.8 g of (1,4) diazepine was obtained.

この物質の融点及び元素分析値は次の通りである。The melting point and elemental analysis values of this substance are as follows.

融 点 207〜208°C 元素分析値 C16H11F4N302 理論値C:54.40 H:3.14 N:11.89
実測値C:54.51 H:3.19 N:11.80
実施例 3 l−(0−クロロフェニル)−4−シクロプロピルメチ
ル−1,3,4,5−テトラヒドロ−3−オキソ−2H
−ピリド(2,3−e)(1,4〕ジアゼピン3.3g
を酢酸30m1に溶解し、K2Cr2078.8 gを
加え70°Cで2時間加熱した。
Melting point 207-208°C Elemental analysis value C16H11F4N302 Theoretical value C: 54.40 H: 3.14 N: 11.89
Actual value C: 54.51 H: 3.19 N: 11.80
Example 3 l-(0-chlorophenyl)-4-cyclopropylmethyl-1,3,4,5-tetrahydro-3-oxo-2H
-pyrido(2,3-e)(1,4]diazepine 3.3g
was dissolved in 30 ml of acetic acid, 2078.8 g of K2Cr was added, and the mixture was heated at 70°C for 2 hours.

反応終了後、溶媒を減圧下留去し残渣に氷水を加え粗結
晶を得た。
After the reaction was completed, the solvent was distilled off under reduced pressure, and ice water was added to the residue to obtain crude crystals.

これをエーテル−石油エーテル混合溶媒より再結晶して
、無色針状晶の1−(O−クロロフェニル)−4−シク
ロプロピルメチル−1,3,4,5−テトラヒト0−3
.5−ジオキソ−2H−ピリド〔2,3−e)〔1,4
〕ジアゼピン2.0gを得た。
This was recrystallized from an ether-petroleum ether mixed solvent to give colorless needle-like crystals of 1-(O-chlorophenyl)-4-cyclopropylmethyl-1,3,4,5-tetrahydro-3
.. 5-dioxo-2H-pyrido[2,3-e)[1,4
] 2.0 g of diazepine was obtained.

この物質の融点及び元素分析値は次の通りであった。The melting point and elemental analysis values of this substance were as follows.

融 点 253〜255°G 元素分析値 Cl8H16CIN302 理論値C:63.25 H:4.72 N:12.29
実測値C:63.30 H:4.67 N:12.27
実施例1〜3の方法に準じて次に示す化合物を合成した
Melting point 253-255°G Elemental analysis value Cl8H16CIN302 Theoretical value C: 63.25 H: 4.72 N: 12.29
Actual value C: 63.30 H: 4.67 N: 12.27
The following compounds were synthesized according to the methods of Examples 1 to 3.

1−(m トリフルオロメチルフェニル)−4−メチ
ル−1,3,4,5−テトラヒドロ−3,5−ジオキソ
−2H−ピリド〔2,3−e〕〔1,4〕ジアゼピン融
点 212〜214°C 1−フェニル−4−メチル−1,3,4,5−テトラヒ
ドロ−3,5−ジオキソ−2H−ピリド(2,3−e〕
〔1,4〕ジアゼピン 融 点 260〜261°C 1−フェニル−4−エチル−1,3,4,5−テトラヒ
ドロ−3,5−ジオキソ−2H−ピリド(2,3−e〕
〔1,4〕ジアゼピン 融 点 207〜209°C 1−(0−クロロフェニル)−4−メチル−1゜3、4
.5−テトラヒドロ−3,5−ジオキソ−2H−ピリド
(2,3−e ) (1,4−)ジアゼピン融 点
240〜241°C 1−(0−クロロフェニル)−4−エチル−1゜3、4
.5−テトラヒドロ−3,5−ジオキソ−2H−ピリド
(2,3−e ) [I 1,4 )ジアゼピン融
点 206〜207°C ■−(0−フルオロフェニル)−4−メチル−1、3,
4,5−テトラヒドロ−3,5−ジオキソ−2H−ピリ
ド(2,3−e ) C1,4)ジアゼピン融 点
202〜203°C
1-(m trifluoromethylphenyl)-4-methyl-1,3,4,5-tetrahydro-3,5-dioxo-2H-pyrido[2,3-e][1,4]diazepine Melting point 212~ 214°C 1-phenyl-4-methyl-1,3,4,5-tetrahydro-3,5-dioxo-2H-pyrido (2,3-e)
[1,4]Diazepine Melting point 260-261°C 1-phenyl-4-ethyl-1,3,4,5-tetrahydro-3,5-dioxo-2H-pyrido (2,3-e)
[1,4]Diazepine Melting point 207-209°C 1-(0-chlorophenyl)-4-methyl-1°3,4
.. 5-tetrahydro-3,5-dioxo-2H-pyrido(2,3-e)(1,4-)diazepine melting point
240-241°C 1-(0-chlorophenyl)-4-ethyl-1°3,4
.. 5-tetrahydro-3,5-dioxo-2H-pyrido (2,3-e) [I1,4) diazepine melt
Point 206-207°C ■-(0-fluorophenyl)-4-methyl-1,3,
4,5-tetrahydro-3,5-dioxo-2H-pyrido(2,3-e) C1,4) diazepine melting point
202~203°C

Claims (1)

【特許請求の範囲】 1 一般式 (式中、Wはフェニル基、ハロゲン原子、トリフルオロ
メチル基が置換したフェニル基を、R2は水素原子、低
級アルキル基、又はハロゲン原子、低級シクロアルキル
基が置換した低級アルキル基を意味する)で表わされる
化合物を酸化することを特徴とする一般式 (式中、R及びRは前記と同じ意味を有する)で表わさ
れる新規なピリド−1,4−ジアゼピンジオン誘導体の
製造法。
[Claims] 1 General formula (wherein W is a phenyl group, a halogen atom, or a phenyl group substituted with a trifluoromethyl group, and R2 is a hydrogen atom, a lower alkyl group, or a halogen atom or a lower cycloalkyl group) A novel pyrido-1,4-di compound represented by the general formula (in which R and R have the same meanings as above), which is characterized by oxidizing a compound represented by a substituted lower alkyl group. Method for producing azepinedione derivatives.
JP225675A 1974-12-27 1974-12-27 Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou Expired JPS58433B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP225675A JPS58433B2 (en) 1974-12-27 1974-12-27 Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP225675A JPS58433B2 (en) 1974-12-27 1974-12-27 Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou

Publications (2)

Publication Number Publication Date
JPS5180889A JPS5180889A (en) 1976-07-15
JPS58433B2 true JPS58433B2 (en) 1983-01-06

Family

ID=11524268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP225675A Expired JPS58433B2 (en) 1974-12-27 1974-12-27 Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou

Country Status (1)

Country Link
JP (1) JPS58433B2 (en)

Also Published As

Publication number Publication date
JPS5180889A (en) 1976-07-15

Similar Documents

Publication Publication Date Title
JPS58433B2 (en) Cinquinapiride -14- Diazepinedione Yudotaino Seizouhou
US3882119A (en) Tetracyclic substituted phthalazine compounds
JPS60226878A (en) 3-amino-1-(4,5,6,7-tetrahydrobenzothiazolyl)-2-pyrazolines and manufacture
JPS60161982A (en) Substituted 4,5-dihydro-6-vinyl-3(2h)-pyridazinone and 6-vinyl-3(2h)-pyridazinone and manufacture
JP4061333B2 (en) 2- (Pyrazol-1-yl) pyridine derivatives
JPH03215488A (en) Pyrimidobenzimidazole derivative
JPS58432B2 (en) Cinquinapiride -1,4- Diazepine
JPS5995286A (en) Imidazo(4,5-c)pyridine-6-carboxylic acid derivative
JPS6051180A (en) Preparation of 1,2,4-triazolin-5-one
JPS5925785B2 (en) Novel carboxylic acid amide derivative
JPS5829792B2 (en) Sinquinapiride (4,3-D) Pyrimidinedione
JP2893906B2 (en) Method for producing unsaturated ketone compound
JPS5942677B2 (en) 100% free of charge
JPS5817194B2 (en) Sinquinapiride (2,3-D)
JPS58429B2 (en) Synquina 2-oxo-1,2,3,4-tetrahydropyride (2,3-D) Pyrimidine
JP2675924B2 (en) Method for producing aminoketones
JPH0399081A (en) Thienoindolizine derivative
JPS5833232B2 (en) Sinquinapyridopyrimidinedione
JPS5920674B2 (en) Pyrido (2,3-D) Pyrimidine
JPS582953B2 (en) How to use pyridopyrimidine dione
JPS5823397B2 (en) Piperidylpenzimidazole
JPS5854158B2 (en) Synquinapyridothiadiagin
JPS61204185A (en) Pyridoimidazopyrazine derivative and production thereof
JPS582947B2 (en) Sinquinapyridopyrimidinedione
JPS5827795B2 (en) Synquina 4-oxo-1,4-dihydropyrido (2,3-D) Pyrimidine